+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 1182822-31-6
1182822-31-6,MFCD21606649
Catalog No.:AA008TC5

1182822-31-6 | 5-Amino-2,4-di-tert-butylphenyl methyl carbonate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95+%
in stock  
$34.00   $24.00
- +
250mg
95+%
in stock  
$52.00   $36.00
- +
1g
95+%
in stock  
$131.00   $92.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA008TC5
Chemical Name:
5-Amino-2,4-di-tert-butylphenyl methyl carbonate
CAS Number:
1182822-31-6
Molecular Formula:
C16H25NO3
Molecular Weight:
279.3746
MDL Number:
MFCD21606649
SMILES:
COC(=O)Oc1cc(N)c(cc1C(C)(C)C)C(C)(C)C
Properties

Downstream Synthesis Route

[1]Patent:WO2010/108162,2010,A1.Locationinpatent:Page/Pagecolumn86;89-90

[2]Patent:US2011/230519,2011,A1.Locationinpatent:Page/Pagecolumn19

[3]Patent:WO2013/158121,2013,A1.Locationinpatent:Page/Pagecolumn53;54

[4]Patent:WO2013/67410,2013,A1.Locationinpatent:Paragraph0096

[5]Patent:US2013/281487,2013,A1.Locationinpatent:Paragraph00581;00582

[6]Patent:WO2014/71122,2014,A1.Locationinpatent:Paragraph00156;00328;00338;00339

[7]Patent:EP2815749,2014,A1.Locationinpatent:Paragraph0239;0240

[8]Patent:WO2015/73231,2015,A1.Locationinpatent:Paragraph00353-00354

[9]Patent:US2015/231142,2015,A1.Locationinpatent:Paragraph0904

[10]Patent:US2016/96807,2016,A1.Locationinpatent:Paragraph0444-0445

[11]Patent:WO2016/57730,2016,A1.Locationinpatent:Paragraph00392;00393

[1]Zhu,Jun;He,Lin;Ma,Liang;Wei,Zhe;He,Jiqiang;Yang,Zhuang;Pu,Yuzhi;Cao,Dong;Wu,Yuzhe;Xiang,Mingli;Peng,Aihua;Wei,Yuquan;Chen,Lijuan[BioorganicandMedicinalChemistryLetters,2014,vol.24,#24,p.5666-5670]

[2]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2010/108162,2010,A1Locationinpatent:Page/Pagecolumn86;88-89

[3]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2011/230519,2011,A1Locationinpatent:Page/Pagecolumn18

[4]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2011/98311,2011,A1

[5]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2013/67410,2013,A1Locationinpatent:Paragraph0092;0093

[6]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2013/185112,2013,A1Locationinpatent:Paragraph00543

[7]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2014/71122,2014,A1Locationinpatent:Paragraph00156;00328;00335;00336

[8]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2014/221424,2014,A1Locationinpatent:Paragraph0083

[9]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2015/73231,2015,A1Locationinpatent:Paragraph00350-00351

[10]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2015/231142,2015,A1Locationinpatent:Paragraph0900

[11]CurrentPatentAssignee:LAURUSLABSLIMITED-WO2017/37672,2017,A1Locationinpatent:Page/Pagecolumn51

[12]Lewandowski,BéréniceL.;Looker,AdamR.;Roeper,Stefanie;Ryan,MichaelP.;Wilde,Nathan;Ye,Zhifeng[JournalofOrganicChemistry,2020]

[13]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US10980746,2021,B2Locationinpatent:Page/Pagecolumn119

[1]Patent:US2011/98311,2011,A1

[2]Patent:US2011/98311,2011,A1

[1]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2011/230519,2011,A1

[2]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2013/67410,2013,A1

[3]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2013/185112,2013,A1

[4]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2014/71122,2014,A1

[5]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2014/221424,2014,A1

[6]Zhu,Jun;He,Lin;Ma,Liang;Wei,Zhe;He,Jiqiang;Yang,Zhuang;Pu,Yuzhi;Cao,Dong;Wu,Yuzhe;Xiang,Mingli;Peng,Aihua;Wei,Yuquan;Chen,Lijuan[BioorganicandMedicinalChemistryLetters,2014,vol.24,#24,p.5666-5670]

[7]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2015/73231,2015,A1

[8]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2015/231142,2015,A1

[9]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2011/98311,2011,A1

[10]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2011/98311,2011,A1

[11]CurrentPatentAssignee:OPTIMUSDRUGSPRIVATE-US2017/96397,2017,A1

[12]Lewandowski,BéréniceL.;Looker,AdamR.;Roeper,Stefanie;Ryan,MichaelP.;Wilde,Nathan;Ye,Zhifeng[JournalofOrganicChemistry,2020]

[13]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US10980746,2021,B2

[1]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2011/230519,2011,A1

[2]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2011/98311,2011,A1

[3]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2011/98311,2011,A1

[4]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2013/67410,2013,A1

[5]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2013/185112,2013,A1

[6]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2014/71122,2014,A1

[7]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2014/221424,2014,A1

[8]Zhu,Jun;He,Lin;Ma,Liang;Wei,Zhe;He,Jiqiang;Yang,Zhuang;Pu,Yuzhi;Cao,Dong;Wu,Yuzhe;Xiang,Mingli;Peng,Aihua;Wei,Yuquan;Chen,Lijuan[BioorganicandMedicinalChemistryLetters,2014,vol.24,#24,p.5666-5670]

[9]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2015/73231,2015,A1

[10]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US2015/231142,2015,A1

[11]Lewandowski,BéréniceL.;Looker,AdamR.;Roeper,Stefanie;Ryan,MichaelP.;Wilde,Nathan;Ye,Zhifeng[JournalofOrganicChemistry,2020]

[12]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-US10980746,2021,B2

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1182822-31-6
873055-55-1

873055-55-1
Building Blocks
More >
Tags:1182822-31-6 Molecular Formula|1182822-31-6 MDL|1182822-31-6 SMILES|1182822-31-6 5-Amino-2,4-di-tert-butylphenyl methyl carbonate